PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $120,000 | -63.0% | 41,269 | -66.5% | 0.02% | -54.3% |
| Q3 2018 | $324,000 | -18.0% | 123,296 | -26.9% | 0.04% | +2.9% |
| Q2 2018 | $395,000 | -41.7% | 168,779 | -26.8% | 0.03% | -39.3% |
| Q1 2018 | $677,000 | +6.6% | 230,417 | -0.6% | 0.06% | +124.0% |
| Q4 2017 | $635,000 | -14.4% | 231,842 | +5.9% | 0.02% | -64.8% |
| Q3 2017 | $742,000 | -24.8% | 218,849 | -45.2% | 0.07% | -21.1% |
| Q2 2017 | $987,000 | +6.0% | 399,443 | -2.7% | 0.09% | -11.8% |
| Q1 2017 | $931,000 | +7.0% | 410,323 | 0.0% | 0.10% | -3.8% |
| Q4 2016 | $870,000 | -32.3% | 410,323 | +6.9% | 0.11% | -24.8% |
| Q3 2016 | $1,286,000 | +189.6% | 383,971 | +171.8% | 0.14% | +151.8% |
| Q2 2016 | $444,000 | +21.0% | 141,264 | +28.2% | 0.06% | +12.0% |
| Q1 2016 | $367,000 | -49.2% | 110,153 | -46.1% | 0.05% | -75.6% |
| Q4 2015 | $723,000 | +288.7% | 204,362 | +452.5% | 0.20% | +253.4% |
| Q3 2015 | $186,000 | -63.3% | 36,988 | -38.4% | 0.06% | -71.3% |
| Q4 2013 | $507,000 | – | 60,054 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |